NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Global Health Limited (NSE: MEDANTA)
MEDANTA Technical Analysis
4
As on 19th Mar 2025 MEDANTA SHARE Price closed @ 1227.85 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1167.11 & Strong Buy for SHORT-TERM with Stoploss of 1117.65 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MEDANTASHARE Price
Open | 1244.50 | Change | Price | % |
High | 1244.50 | 1 Day | -7.40 | -0.60 |
Low | 1218.65 | 1 Week | 59.55 | 5.10 |
Close | 1227.85 | 1 Month | 78.50 | 6.83 |
Volume | 140611 | 1 Year | 17.50 | 1.45 |
52 Week High 1487.05 | 52 Week Low 438.45 |
NSE INDIA Most Active Stocks
IDEA | 7.44 | 4.79% |
EASEMYTRIP | 13.16 | 2.33% |
JPPOWER | 14.75 | 10.24% |
YESBANK | 17.03 | 3.59% |
SUZLON | 57.76 | 5.06% |
GTLINFRA | 1.53 | 3.38% |
TATASTEEL | 158.60 | 2.55% |
ZOMATO | 223.53 | 2.45% |
SAIL | 113.23 | 3.97% |
RPOWER | 37.72 | 8.39% |
NSE INDIA Top Gainers Stocks
GRSE | 1641.35 | 20.00% |
VSTL | 155.83 | 20.00% |
KSOLVES | 410.55 | 19.99% |
ASIANENE | 287.41 | 19.39% |
SINDHUTRAD | 19.08 | 19.32% |
TANLA | 520.60 | 17.54% |
DOLATALGO | 85.96 | 17.03% |
BROOKS | 118.50 | 16.30% |
MANAKSTEEL | 54.19 | 14.91% |
IDEAFORGE | 383.90 | 14.14% |
NSE INDIA Top Losers Stocks
MEDANTA Daily Charts |
MEDANTA Intraday Charts |
Whats New @ Bazaartrend |
MEDANTA Free Analysis |
|
MEDANTA Important Levels Intraday
RESISTANCE | 1277.66 |
RESISTANCE | 1261.69 |
RESISTANCE | 1251.81 |
RESISTANCE | 1241.94 |
SUPPORT | 1213.76 |
SUPPORT | 1203.89 |
SUPPORT | 1194.01 |
SUPPORT | 1178.04 |
MEDANTA Target March 2025
4th UP Target | 1306.59 |
3rd UP Target | 1220.96 |
2nd UP Target | 1168.04 |
1st UP Target | 1115.11 |
1st DOWN Target | 964.09 |
2nd DOWN Target | 911.16 |
3rd DOWN Target | 858.24 |
4th DOWN Target | 772.61 |
MEDANTA Weekly Target
4th UP Target | 1377.88 |
3rd UP Target | 1313.79 |
2nd UP Target | 1274.18 |
1st UP Target | 1234.57 |
1st DOWN Target | 1121.53 |
2nd DOWN Target | 1081.92 |
3rd DOWN Target | 1042.31 |
4th DOWN Target | 978.22 |
MEDANTA Target2025
4th UP Target | 2631.47 |
3rd UP Target | 2133.42 |
2nd UP Target | 1825.57 |
1st UP Target | 1517.72 |
1st DOWN Target | 639.28 |
2nd DOWN Target | 331.43 |
3rd DOWN Target | 23.58 |
4th DOWN Target | -474.47 |
Global Health Limited ( NSE INDIA Symbol : MEDANTA )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
MEDANTA Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
MEDANTA Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
MEDANTA Address
![]() |
MEDANTA Latest News
MEDANTA Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service